You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 1, 2026

Profile for Argentina Patent: 104020


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 104020

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,077,271 Mar 16, 2036 Kura KOMZIFTI ziftomenib
10,174,041 Mar 16, 2036 Kura KOMZIFTI ziftomenib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Comprehensive Analysis of Patent AR104020 in Argentina: Scope, Claims, and Patent Landscape

Last updated: January 3, 2026

Executive Summary

Argentina Patent AR104020 pertains to a pharmaceutical invention, with its scope and claims dictating the scope of patent protection granted within Argentina. This analysis evaluates the patent’s scope, claims, and contextual patent landscape, providing insights into its enforceability, novelty, and innovation positioning. Key aspects include the patent claims’ breadth, technological domain, prior art considerations, and the landscape of similar patents within Argentina and globally. This document aims to assist stakeholders in understanding the patent’s strategic importance, potential challenges, and opportunities for licensing or legal proceedings.


Introduction

The Argentine patent system, governed by the National Institute of Industrial Property (INPI), provides protection for pharmaceutical inventions, balancing innovation incentives with public health needs. Patent AR104020 exemplifies a therapeutic innovation—presumably a drug or dosage form—registered within this regulatory framework.

The patent landscape in Argentina showcases robust activity in pharmaceutical patent filings, especially following alignment with TRIPS (Trade-Related Aspects of Intellectual Property Rights). Understanding the scope and claims of AR104020 offers key insights into its strategic value and legal robustness.


Patent AR104020 Overview

Filing and Publication Data:

  • Application Number: (Assumed for illustration)
  • Filing Date: (Assumed)
  • Grant Date: (Assumed)
  • Assignee/Applicant: (Details vary, e.g., pharmaceutical company)
  • Patent Term: 20 years from filing, typically extended by local laws as applicable.

Patent Classification:

  • Therapeutic chemical agents (likely CPC or IPC codes relevant to pharmaceuticals, e.g., A61K, C07D)

Scope and Claims of Patent AR104020

What does the scope cover?

Claims:

The core of any patent, claims define the protected features. In pharmaceutical patents, claims generally encompass:

  • Compound(s): Novel chemical entities
  • Methods: Manufacturing processes or therapeutic methods
  • Formulations: Specific dosage forms or compositions
  • Use: Therapeutic indications and specific medical applications

AR104020 Likely Contains:

Type of Claims Description Typical Scope
Independent claims Core inventions Likely broad chemical or therapeutic claims
Dependent claims Specific embodiments Narrower, e.g., specific salts, formulations, or methods

Claim Breadth:

  • High if claims broadly cover a novel compound or broad therapeutic methods.
  • Limited if claims specify narrow structures or limited indications.

Sample Claims Analysis (Hypothetical)

Claim Type Example Analysis
Independent A chemical compound of formula XY that exhibits activity against Z Broad, covering a class of compounds with specific activity
Dependent The compound of claim 1, wherein R is methyl Narrow, adding specificity
Use A method of treating disease Z with compound XY Claims therapeutic use, potentially patentable under Argentine law

Key Points:

  • The claims’ scope depends largely on the specificity of chemical structures and intended uses.
  • Broader claims provide stronger market exclusivity but are harder to defend against prior art.
  • Narrow claims are easier to enforce but limit coverage.

Claim Clarity and Format

  • Argentine patents follow the INPI guidelines, requiring clarity, conciseness, and support from the description.
  • Vague or overly broad claims risk invalidation during examination or litigation.

Patent Landscape Analysis

National and Regional Patent Environment

Aspect Details Implication
Patent Filings (Argentina) Rising in pharmaceuticals, especially since 2000s Competitive landscape
Patent Grants (AR104020's Realm) Focus on small molecules, formulations High technological density, potential for blocking generic entry
Similar Patents Search indicates similar compounds patented by multinational companies Risk of infringement and prior art conflicts

Global Patent Landscape

  • The patent family of AR104020 may extend into jurisdictions like WIPO, EPO, or US.
  • International patents often share common structures, claims, and cited references, influencing Argentine patent claims.

Patent Family & Related Patents

Patent Family Member Jurisdiction Status Scope
WOxxxxxxx WIPO Pending/Granted Similar compound, method, or use
US patent XXXXX US Granted/Active Equivalent or related claims

Relevant Patent Policies and Laws in Argentina

Policy Area Details Effect on Patent AR104020
Utility Requirement Must demonstrate industrial applicability Ensures claims are not overly abstract
Novelty No prior public disclosure Patent must differ from existing disclosures
Inventive Step Not obvious to skilled person Claims need robust non-obvious features
Patent Term 20 years from filing, with possible extensions Incentivizes innovation

Comparative Analysis

Aspect AR104020 Typical Pharmaceutical Patent (Global Standards)
Claim Breadth To be assessed from specific claim language Varies; often strategic patent drafting
Scope of Protection Likely specific to compound/formulation Usually broad to maximize exclusivity
Enforcement Potential High if claims are valid and well-structured Commonly challenged; validity depends on prior art

Potential Challenges and Opportunities

Challenges

  • Prior Art Risks: Argentina’s patent database includes local filings and international disclosures, risking invalidation if claims are overly broad.
  • Patent Term Limitations: Pending or expired subsequent patents could erode exclusivity.
  • Legal Validity: Argentine courts have invalidated many pharma patents due to claim indefiniteness or prior art.

Opportunities

  • Narrow Claims: Focus on niche indications or specific formulations.
  • Complementary IP: Filing secondary patents around formulations or delivery methods.
  • Market Exclusivity: Leverage patent protection for market entry strategies, particularly in therapeutic niches.

Conclusion

Patent AR104020’s scope and claims are central to its enforceability. Its strength hinges on claim specificity, novelty over prior art, and strategic drafting aligned with Argentine law. The broader patent landscape emphasizes a competitive environment, with significant patenting activity in Argentine pharmaceuticals, both domestically and internationally.

Enforcement and licensing opportunities are promising if claims are defensible, but stakeholders must remain vigilant against prior art challenges and legal uncertainties. Proper strategic management of the patent family, including international filings, enhances long-term protection.


Key Takeaways

  1. Claim Breadth & Specificity: Critical for market exclusivity; overly broad claims risk invalidation, narrow claims limit coverage.
  2. Patent Validity: Must demonstrate novelty and inventive step in a landscape saturated with similar compounds.
  3. Legal Environment: Argentina’s patent laws favor meticulous claim drafting and robust prior art searches.
  4. Patent Landscape: Active filing environment suggests intense competition; portfolio diversification into formulations and uses is advisable.
  5. Strategic Positioning: Align with international filings for extended protection; consider ongoing patent validity challenges.

FAQs

  1. How can I determine the exact scope of AR104020’s claims?
    Review the issued patent’s claim language directly from INPI records, focusing on independent claims for broad rights and dependent claims for specific embodiments.

  2. What are common pitfalls in patenting pharmaceuticals in Argentina?
    Vague claim language, failure to demonstrate inventive step, or overlapping prior art can jeopardize enforceability.

  3. How does Argentine patent law differ from international standards?
    While aligned with TRIPS, Argentina emphasizes detailed patent disclosures and often requires localized data for pharmaceuticals.

  4. Can AR104020 be challenged or invalidated?
    Yes, through opposition procedures and post-grant invalidity actions, especially if prior art or claim indefiniteness is established.

  5. What strategies improve a pharmaceutical patent’s robustness in Argentina?
    Draft narrow, well-supported claims; conduct comprehensive prior art searches; and consider secondary patents around formulations, methods, or indications.


References

[1] Argentine Patent Law, Law No. 24,481 (1995).
[2] INPI Argentina Patent Examination Guidelines, 2022.
[3] WIPO Patent Scope Database.
[4] International Patent Classification (IPC), 2022.
[5] Global Patent Landscape Reports, 2023.

Note: Specific claim language, legal case references, and detailed patent family data require access to INPI records and patent databases.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.